Key Event Components

  • Key Event Components (KECs) are used to describe Key Events (KEs) in a computable way, by defining an action, processes, and object term that maps to controlled vocabulary and ontology terms.
  • KECs on this page can be filtered by the action, process, and object terms, as well as by source ontologies.
  • Link to source ontology terms are provided in cases where the URL was available when the ontology terms were added to the AOP-Wiki database.
  • A complete list of all KECs is available in TSV format on the Downloads Page.
Showing 226 to 250 of 1160 KECs
Clear Table Filters
ID Action Process Object Associated Key Events (KEs)
935 occurrence toll-like receptor 7 signaling pathway (GO:0034154) viral genome (GO:0019015) None
934 occurrence toll-like receptor 3 signaling pathway (GO:0034138) viral genome (GO:0019015) None
933 occurrence inhibition of host DNA replication by virus (GO:0098673) interferon regulatory factor 3 complex (GO:0097072) None
932 occurrence membrane fusion (GO:0061025) vesicle membrane (GO:0012506) 2159: Influenza A virus (IAV) cell entry
931 occurrence receptor-mediated endocytosis (GO:0006898) influenzavirus hemagglutinin (PR:000049750) 2159: Influenza A virus (IAV) cell entry
930 occurrence protein localization to endosome (GO:0036010) clathrin-coated vesicle membrane (GO:0030665) 2159: Influenza A virus (IAV) cell entry
929 occurrence receptor-mediated endocytosis (GO:0006898) clathrin-coated vesicle membrane (GO:0030665) None
928 occurrence receptor binding (GO:0005102)
927 disrupted intercellular transport (GO:0010496) 2096: Occurrence, (Micro)vascular dysfunction
926 functional change smooth muscle cell (CL:0000192) 2096: Occurrence, (Micro)vascular dysfunction
925 functional change pericyte cell (CL:0000669) 2096: Occurrence, (Micro)vascular dysfunction
924 functional change blood vessel endothelial cell (CL:0000071) 2096: Occurrence, (Micro)vascular dysfunction
923 decreased signaling (GO:0023052) neurotransmitter (CHEBI:25512) 2151: Disruption, neurotransmitter release
922 increased calcium amount (VT:0010499) calcium(2+) (CHEBI:29108) 1339: Increase, intracellular calcium
921 increased kinase activity (GO:0016301) astrocyte (CL:0000127) 2146: Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2
920 increased Insulin resistance (HP:0000855) 2119: Increase, Insulin resistance
919 increased respiratory electron transport chain (GO:0022904) superoxide (CHEBI:18421) 2120: Superoxide generation, increased
918 decreased succinate metabolic process (GO:0006105) succinate dehydrogenase complex (GO:0045281) 2118: Succinate dehydrogenase, inhibited
917 decreased FAD metabolic process (GO:0046443) succinate dehydrogenase complex (GO:0045281) 2118: Succinate dehydrogenase, inhibited
916 decreased succinate dehydrogenase activity (GO:0000104) 2118: Succinate dehydrogenase, inhibited
915 increased blood coagulation, fibrin clot formation (GO:0072378) Fibrin (CHEBI:5054) 1846: Thrombosis and Disseminated Intravascular Coagulation
914 decreased fibrinolysis (GO:0042730) 1846: Thrombosis and Disseminated Intravascular Coagulation
913 decreased fibrinolysis (GO:0042730) Fibrin (CHEBI:5054) None
912 occurrence abnormal blood coagulation (MP:0002551) blood (UBERON:0000178) 1845: Coagulation
911 decreased abnormal glutathione level (MP:0012603) glutathione (CHEBI:16856) 130: Depletion, GSH